Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Tax Provisions: 2023-2025

Historic Tax Provisions for Eton Pharmaceuticals (ETON) over the last 2 years, with Sep 2025 value amounting to -$28,000.

  • Eton Pharmaceuticals' Tax Provisions rose 77.78% to -$28,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $199,000, marking a year-over-year change of. This contributed to the annual value of $15,000 for FY2024, which is 93.93% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Tax Provisions stood at -$28,000 for Q3 2025, which was down 142.42% from $66,000 recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Tax Provisions high stood at $247,000 for Q4 2023, and its period low was -$126,000 during Q3 2024.
  • For the 3-year period, Eton Pharmaceuticals' Tax Provisions averaged around $53,429, with its median value being $66,000 (2025).
  • Its Tax Provisions has fluctuated over the past 5 years, first tumbled by 64.78% in 2024, then spiked by 77.78% in 2025.
  • Quarterly analysis of 3 years shows Eton Pharmaceuticals' Tax Provisions stood at $247,000 in 2023, then tumbled by 64.78% to $87,000 in 2024, then spiked by 77.78% to -$28,000 in 2025.
  • Its Tax Provisions stands at -$28,000 for Q3 2025, versus $66,000 for Q2 2025 and $74,000 for Q1 2025.